156 related articles for article (PubMed ID: 14558344)
21. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.
Dos Santos L; de Andrade TG; Zangrossi Junior H
Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111
[TBL] [Abstract][Full Text] [Related]
22. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
Eskow KL; Gupta V; Alam S; Park JY; Bishop C
Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
[TBL] [Abstract][Full Text] [Related]
23. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
Khan A; Haleem DJ
Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
[TBL] [Abstract][Full Text] [Related]
24. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans.
Coccaro EF; Gabriel S; Siever LJ
Psychopharmacol Bull; 1990; 26(3):393-405. PubMed ID: 2274641
[TBL] [Abstract][Full Text] [Related]
25. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
[TBL] [Abstract][Full Text] [Related]
26. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.
McAllister-Williams RH; Massey AE; Fairchild G
J Psychopharmacol; 2007 Nov; 21(8):826-32. PubMed ID: 17715208
[TBL] [Abstract][Full Text] [Related]
27. Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors.
Kumar JR; Rajkumar R; Lee LC; Dawe GS
Neuropharmacology; 2016 Nov; 110(Pt A):1-14. PubMed ID: 27436722
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
Peng WH; Wu CR; Chen CS; Chen CF; Leu ZC; Hsieh MT
Life Sci; 2004 Oct; 75(20):2451-62. PubMed ID: 15350820
[TBL] [Abstract][Full Text] [Related]
29. [Differences in the effects of naltrexone on the communicative and aggressive behaviors of subjects with different experiences of social conquests].
Lipina TV; Avgustinovich DF; Koriakina LA; Aleksaeenko OV; Kudriavtseva NN
Eksp Klin Farmakol; 1998; 61(3):13-8. PubMed ID: 9690068
[TBL] [Abstract][Full Text] [Related]
30. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
[TBL] [Abstract][Full Text] [Related]
31. Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats.
Lim LW; Temel Y; Sesia T; Vlamings R; Visser-Vandewalle V; Steinbusch HW; Blokland A
Neuroscience; 2008 Jul; 155(1):164-73. PubMed ID: 18588948
[TBL] [Abstract][Full Text] [Related]
32. Serotoninergic mechanisms of immunomodulation under different psychoemotional states: I. A role of 5-HT 1A receptor subtype.
Idova G; Davydova S; Alperina E; Cheido M; Devoino L
Int J Neurosci; 2008 Nov; 118(11):1594-608. PubMed ID: 18853336
[TBL] [Abstract][Full Text] [Related]
33. Effect of acute and chronic buspirone administration on communicativeness of mice with experience of defeats in social conflicts.
Avgustinovich DF; Vishnivetskaya GB; Koryakina LA
Bull Exp Biol Med; 2010 Jul; 149(1):57-61. PubMed ID: 21113459
[TBL] [Abstract][Full Text] [Related]
34. [Buspirone--a wide-spectrum preparation].
Molodavkin GM; Voronina TA
Eksp Klin Farmakol; 1997; 60(2):3-6. PubMed ID: 9206564
[TBL] [Abstract][Full Text] [Related]
35. Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat.
Sivarao DV; Newberry K; Lodge NJ
Eur J Pharmacol; 2004 Jun; 494(1):23-9. PubMed ID: 15194447
[TBL] [Abstract][Full Text] [Related]
36. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
37. [Effect of sodium valproate on aggressive behavior of male mice with various aggression experience].
Smagin DA; Bondar' NP; Kudriavtseva NN
Eksp Klin Farmakol; 2010 Jan; 73(1):10-5. PubMed ID: 20184281
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
Moser PC
Psychopharmacology (Berl); 1989; 99(1):48-53. PubMed ID: 2528779
[TBL] [Abstract][Full Text] [Related]
39. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
Grundmann O; Nakajima J; Seo S; Butterweck V
J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
[TBL] [Abstract][Full Text] [Related]
40. Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli.
Bond AJ; Wingrove J; Baylis M; Dalton J
Psychopharmacology (Berl); 2003 Jan; 165(3):291-5. PubMed ID: 12420156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
